Ultimovacs
Menu Close ✕
  • About
    • About Ultimovacs
    • Team
    • Board of directors
  • Technology
    • Technology overview
    • Immunotherapy
    • Clinical studies
  • Investors
    • Shares
    • Reports and presentations
    • Investor relations contacts
    • Analyst coverage
    • Governance
    • News
  • Contact

Enabling the immune system to fight cancer

Ultimovacs is a pharmaceutical company developing novel immunotherapies against cancer.

Read more about Ultimovacs

Our mission is to extend and improve the life of patients by directing the immune system against the core of cancer.

We will provide universally accessible solutions.

Tweets | @Ultimovacs

Press Releases

Ultimovacs ASA – Announces the Appointment of Ton Berkien as Chief Business Officer 24, November, 2020
Ultimovacs ASA: Third quarter 2020 result presentation 12, November, 2020
Ultimovacs ASA – Extraordinary General Meeting held on 11 November 2020 11, November, 2020
Ultimovacs ASA: Invitation to third quarter 2020 results webcast presentation 9, November, 2020
Ultimovacs ASA – Disclosure of voting rights of Extraordinary General Meeting 3, November, 2020
See all

News

Full version of the publication in ‘Frontiers in Immunology’ featuring positive results from Phase I trial evaluating UV1 in Non-Small Cell Lung Cancer is now available 26, November, 2020
BioStock has done a piece on Ultimovacs’ main advancements in the Q3-2020 period 17, November, 2020
Interview with Carlos de Sousa in Nordic Life Science magazine 17, November, 2020
Sara Mangsbo recieves 2020 SITC Team Science Award 12, November, 2020
Upcoming conferences 26, October, 2020
BioStock has published the article: “Ultimovacs in the fight against Melanoma” 8, October, 2020
BioStock has published an in-depth article on Ultimovacs 24, September, 2020
See all
E-mail: mail@ultimovacs.com
Phone number: +47 413 80 080
Ullernchausséen 64
0379 Oslo
Norway View in Google Maps

Technology

  • Technology
  • Clinical studies
  • Immunotherapy

Ultimovacs

  • About Ultimovacs
  • Team
  • Board of directors
  • Contact us

Investors

  • Share information
  • Financial reports
  • Investor relations contacts
  • News
Copyright © Ultimovacs ASA 2020